VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure

Back

ESC Professional Premium Access

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure

Session: HOT LINE 2

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

109 presentations

8 followers

10 more presentations in this session

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure

Speaker: Doctor D. Berg (Boston, US)

Discussant review - DAPA ACT HF-TIMI 68

Speaker: Professor B. Bozkurt (Houston, US)

Access

Slides

Video

Panel discussion - DAPA ACT HF-TIMI 68

Access

Video

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction

Speaker: Professor J. Butler (Dallas, US)

Discussant review - VICTOR and VICTORIA

Speaker: Professor J. McMurray (Glasgow, GB)

Access the full session

HOT LINE 2

Speakers: Professor F. Zannad, Doctor D. Berg, Professor B. Bozkurt, Professor J. Butler, Professor J. McMurray

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

29 August 2025

ESC Premium Access

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure

30 August 2025

ESC Premium Access

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction

30 August 2025

ESC 365 is supported by

Explore sponsored resources

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure

About the speaker

Professor Faiez Zannad

10 more presentations in this session

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure

Discussant review - DAPA ACT HF-TIMI 68

Panel discussion - DAPA ACT HF-TIMI 68

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction

Discussant review - VICTOR and VICTORIA

Access the full session

HOT LINE 2

About the event

ESC Congress 2025

Related content

DIGIT-HF: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

DAPA ACT HF-TIMI 68: Dapagliflozin in Patients Hospitalized for Acute Heart Failure

VICTOR: Vericiguat Global Study in Participants with Chronic Heart Failure and VICTORIA: Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction

ESC 365 is supported by